v3.21.1

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
CURRENT ASSETS:
Cash and cash equivalents	$ 10,135	$ 14,671
Restricted cash (Note 6)	1,000
Prepaid expenses and other receivables	1,024	297
TOTAL CURRENT ASSETS	12,159	14,968
NON-CURRENT ASSETS:
Property and equipment, net	869	1,394
Operating lease right-of-use assets	685	817
Other assets (Note 3a)	3,717	3,717
TOTAL NON-CURRENT ASSETS	5,271	5,928
TOTAL ASSETS	17,430	20,896
CURRENT LIABILITIES -
Trade	183	368
Other (Note 5)	5,020	4,966
TOTAL CURRENT LIABILITIES	5,203	5,334
LONG-TERM LIABILITIES -
Operating lease liabilities	178	338
Other liabilities	705	691
TOTAL LONG-TERM LIABILITIES	883	1,029
TOTAL LIABILITIES	6,086	6,363
COMMITMENTS AND CONTINGENT LIABILITIES (Note 3)
SHAREHOLDERS’ EQUITY:
Ordinary shares, with no par value - authorized: 17,500,000 Ordinary Shares as of March 31, 2021 and December 31, 2020; issued and outstanding: 4,502,578 and 4,321,296 Ordinary Shares as of March 31, 2021 and December 31, 2020, respectively	727	727
Additional paid-in capital	218,397	217,357
Accumulated deficit	(207,780)	(203,551)
TOTAL SHAREHOLDERS’ EQUITY	11,344	14,533
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 17,430	$ 20,896

Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Intec Pharma Ltd. 10-Q